TORONTO, ON / ACCESSWIRE / October 7, 2024 / Theralase® Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development ...

Pharma stock Theralase Technologies (TSXV:TLT) announced a significant update on its ongoing bladder cancer clinical study ...

Prostate cancer is a major health concern for men worldwide — often developing without any immediate warning signs. Catching ...

Northwestern raised a record $1.05 billion in research funding this fiscal year, a 5% increase since 2023. The Daily compiled ...

Enfortumab vedotin plus pembrolizumab was previously granted a priority review designation from the MHLW.

Prostate cancer is a major health concern in Louisiana, where it is the second leading cause of cancer death in men. Of every ...

In many cases, prostate cancer doesn’t cause any symptoms at all. The best way of detecting prostate cancer early is with a ...

Cancer patients told DailyMail.com how they hid their diagnoses for different reasons, including a fear of being treated ...

Whether extended lymphadenectomy is associated with improved disease-free and overall survival, as compared with standard lymphadenectomy, among patients with localized muscle-invasive bladder ...

The subtypes investigated in bladder cancer were CK19, CK20 and CK7 IHC/RT-PCR CK20: 56–46% [98,99]; CK7: 100% [99]; CK1: 93.1% [101] Association of CK19 with UPII detected pN0 patients with ...

Indocyanine green is the most widely utilized due to its high sensitivity, specificity, low background fluorescence, and safety profile. In prostate and bladder cancer lymph node dissection, the ...

A blood test, performed when metastatic prostate cancer is first diagnosed, can predict which patients are likely to respond ...